Full-length sequence
Carries all 44 residues of the native releasing hormone rather than the 1-29 fragment.
These are results measured on this lot. Full material specification is in Know your compound.
Growth Hormone Releasing Peptide
A stabilised full-length GHRH(1-44) analog with an extensive clinical literature.
$52.50 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
Tesamorelin is a synthetic analog of the complete 44-residue growth-hormone-releasing hormone, modified at the N-terminus with a trans-3-hexenoyl group that blocks the enzymatic cleavage which rapidly inactivates the native hormone.
It is distinguished from sermorelin and CJC-1295 by carrying the full 1-44 sequence rather than the truncated 1-29 fragment, and it is the most thoroughly characterised GHRH analog in the published clinical record — most of that work concerns visceral adipose tissue in specific patient populations, which is a clinical literature, not a description of this material.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis. Nothing on this page describes an approved therapy or a use in humans.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Carries all 44 residues of the native releasing hormone rather than the 1-29 fragment.
The hexenoyl modification is studied for its role in resisting dipeptidyl peptidase cleavage.
The compound class has been examined in controlled trials with adipose-tissue endpoints; those findings describe the studied population, not this product.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-076
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. Tesamorelin is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.